CLDN18 and gastric cancer: Also, gastric cancer cell with CLDN18-ARHGAP fusion gene could activate PI3K/AKT-mTOR-FAS signaling, which enhances free fatty acid production of gastric cancer cells to favor the survival of Treg cells and contribute to immune suppression.